FORMOSA PHARMACEUTICALS , INC.
Update：2025/12/24
Industries
Main Industry
Health Care
Main Product/Service
Formosa Pharma leverages its proprietary APNT® nanoparticle formulation platform to develop a diversified pipeline, including an FDA‑approved ophthalmic nanosuspension and biosimilar or new chemical entity candidates for cancer and anti‑infective applicat
Founded Year
2010
Unified Business No.
53273211
Status
Active
Number of Employees
0
Total Paid-in
Capital
1,509,771,000 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2021)、Listing(2024)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
Formosa Pharmaceuticals, Inc. is a Taipei‑based clinical‑stage biopharmaceutical company focusing on the development of novel therapies for ophthalmology and oncology.
